x
ServiziMenu principaleHome
You are here: Home > About us > ESO core faculty > Cancer Prevention
Print

Cancer Prevention

Omalkhair Abulkhair, King Abdulaziz Medical City for National Guard, Dept. of Oncology, Riyadh, Saudi Arabia
Adriana Albini, IRCCS MultiMedica, Vascolar Biology and Angiogenesis Dpt., Milan, Italy
Sanaa Al Sukhun, Amman, Jordan
Antonis Antoniou, University of Cambridge, Public Health and Primary care, Cambrideg, United Kingdom
Nadir Arber, The Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Melina Arnold
, International Agency for Research on Cancer (WHO/IARC), Section of Cancer Surveillance, Lyon, France
Banu Arun
, University of Texas MD Anderson Cancer Center, Breast Medical Oncology and Clinical Cancer Genetics Dpt., Houston, USA
Francisco Javier Bosch José, Catalan Institute of Oncology, Cancer Epidemiology Research Programme, L’Hospitalet de Llobregat, Barcelona, Spain
Peter Boyle, iPRI - International Prevention Research Institute, President, Ecully, France
Paolo Bruzzi, National Institute for the Research on Cancer, Clinical Epidemiology Dpt., Genoa, Italy
Franco Cavalli, Hospital San Giovanni, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Eduardo Cazap, Latinamerican & Caribbean Society of Medical Oncology, Buenos Aires,
Argentina
Jack Cuzick, Queen Mary University of London, Wolfson Institute of Preventive Medicine, Centre for Cancer Prevention, London, United Kingdom
Harry de Koning, Erasmus MC, Public Health Dpt., Rotterdam, The Netherlands
Christophorus de Wolf
, Development and evaluation of health politics (ADSAN), Geneva, Switzerland
Louis Denis, Oncology Centre Antwerp, Europa Uomo, Antwerp, Belgium
Margaret Foti, American Association for Cancer Research, Philadelphia, USA
William D. Foulkes, McGill University, Dept. of Human Genetics, Montreal, Canada
Silvia Franceschi, International Agency for Research on Cancer (WHO/IARC, Infections and Cancer Epidemiology Group, Lyon, France
Milo Frattini, Cantonal Institute of Pathology, Molecular Pathology Dpt., Locarno, Switzerland
Sara Gandini, European Institue of Oncology, Dept. of Epidemiology and Biostatistics, Milan, Italy
Patricia Ganz, Jonsson Comprehensive Cancer Center - DCPCR, Dept. of Health Policy and Management, Los Angeles, USA
Gemma Gatta, IRCCS Foundation – National Cancer Institute, Evaluative Epidemiology Dpt., Milan, Italy
Livia Giordano, S. Giovanni Battista Hospital and Turin University, Unit of Epidemiology, CPO Piemonte, Turin, Italy
Joseph Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Dept. of Medical Oncology, Paris, France
Murat Gultekin, Turkish Ministry of Health, Cancer Control Department, Ankara, Turkey
Rema Gvamichava, Georgian National Cancer Center, Surgery Dpt., Tbilisi, Georgia
Michael Häfner, Central Hospital Bolzano, Department of Gastroenterology and Hepatology, Bolzano, Italy
Anthony Howell, Christie Oncology/Genesis Breast Cancer Prevention, Medical Oncology and Prevention Dpt., Manchester, United Kingdom
Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, Bosnia and Herzegovina
John Ioannidis, Stanford Prevention Research Center, Stanford, USA
Ian Magrath, INCTR Int. Network for Cancer Treatment and Research, President Office, Brussels, Belgium
Jose M. Martin Moreno, University of Valencia, Preventive Medicine and Public Health, Valencia, Spain
Gilberto Morgan, Skane University Hospital, Oncology and Surgery Dpt., Lund, Sweden
Ugo Pastorino
, National Institute for the study and the cure of Cancer, Thoracic Surgery Dpt., Milan, Italy
Michael Pollak, Mc Gill University, Dept. of Oncology, Montreal, Quebec, Canada
Marco Rosselli Del Turco, Roma, Italy
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, Belgium
Fritz Schröder, Erasmus University, Dept. of Urology, Rotterdam, The Netherlands
Peter Siersema, Radboud University Medical Center, Dept. of Gastroenterology and Hepatology, Nijmegen, The Netherlands
Michael Sporn, Dartmouth Medical School, Dept. Pharmacology and Toxicology, Hanover, USA
Paul Sugarbaker, Washington Cancer Institute, Dept. of Surgical Oncology, Washington DC, USA
Riccardo Valdagni, IRCCS Foundation – National Cancer Institute, Prostate Cancer Programme and Division of Radiation Oncology 1, Milan, Italy
Paolo Vineis, Imperial College London, Dept. of Epidemiology and Biostatistics, London, United Kingdom
David Zaridze, Institute of Carcinogenesis, Russian N.N.Blokhin Cancer Research Centre, Institute of Carcinogenesis, Moscow, Russian Federation

Follow us